Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

UW-Madison said reductions in NIH funding will "ultimately harm the livelihoods of real people across Wisconsin and the ...

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive ...

The type of bacteria in your mouth may affect your memory, attention and thinking abilities, a study suggests.

A new blood test is being trialed in the UK to detect the early signs of dementia. It is hoped it could identify patients ...

Ongoing collaboration between Eisai and Biogen indicates a strong partnership in the development and commercialization of new treatments for Alzheimer's disease. The European Commission has ...